A Pilot Trial of Lirilumab with or without Azacitidine for patients with Myelodysplastic Syndrome

ConclusionLirilumab either as a single as well as in combination with azacitidine has clinical activity in MDS. Further studies are needed to confirm our findings.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research